SCHEMBL3342528

SCHEMBL3342528

NN1C=Cc2ccccc2O1

nearest known ligand 0.37

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3235007 0.74 KDM4E (0.33) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL5494922 0.74 KDM4E (0.33) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL22115886 0.74 KDM4E (0.33) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL1491181 0.74 KDM4E (0.33) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL1661412 0.74 BRD4 (0.34) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL10592009 0.74 KDM4E (0.34) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL2638049 0.74 KDM4E (0.34) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL5999468 0.71 LMNA (0.42) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL15201897 0.71 HTR2C (0.32) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL23346752 0.69 HTR2C (0.31) KDM4EMEN1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118109945-A High-strength flame-retardant elastic fabric and preparation method thereof 合肥楚欣纺织有限公司 2024-05-31 CN claimed
CN-105164131-A Tricyclic heterocycles as bet protein inhibitors INCYTE CORP 2015-12-16 CN claimed
US-6679923-B2 HAIR DYEING FORMULATION CONTAINING PYRAZOLIN-4,5-DIONES AND AT LEAST ONE AROMATIC PRIMARY AMINE ENABLES THE DYEING OF KERATIN FIBERS WITHOUT AND OXIDIZING AGENT IN SHADES WHICH ARE STRONG, VARIED, RESISTANT AND LESS SELECTIVE L'OREAL S.A. (FR) 2004-01-20 US claimed
US-20020194685-A1 Composition for dyeing keratin fibres, comprising a pyrazoline-4, 5-dione and an aromatic primary amine L'OREAL S.A. (FR) 2002-12-26 US claimed
US-6464732-B2 HAIR DYE MIXTURE L'OREAL S.A. (FR) 2002-10-15 US claimed
US-20020040508-A1 COMPOSITION FOR DYEING KERATIN FIBRES,COMPRISING A PYRAZOLIN-4,5-DIONE AND AN AROMATIC PRIMARY AMINE L'OREAL S.A. (FR) 2002-04-11 US claimed
EP-1144408-A1 SUBSTITUTED 1-(PIERIDIN-4-YL)-3-(ARYL) ISOTHIOUREAS THEIR PREPARATION AND THERAPEUTIC APPLICATION PIERRE FABRE MEDICAMENT (FR) 2001-10-17 EP claimed
WO-2000043391-A1 SUBSTITUTED 1-(PIERIDIN-4-YL)-3-(ARYL) ISOTHIOUREAS THEIR PREPARATION AND THERAPEUTIC APPLICATION PIERRE FABRE MEDICAMENT (FR) 2000-07-27 WO claimed
EP-0981320-A1 COMPOSITION FOR DYEING KERATIN FIBRES COMPRISING A PYRAZOLIN-4,5-DIONE AND AN AROMATIC PRIMARY AMINE L'OREAL (FR) 2000-03-01 EP claimed
WO-1998051268-A1 COMPOSITION FOR DYEING KERATIN FIBRES COMPRISING A PYRAZOLIN-4,5-DIONE AND AN AROMATIC PRIMARY AMINE L'OREAL (FR) 1998-11-19 WO claimed
EP-0103797-B1 SUBSTITUTED BENZOXAZINE DERIVATIVES BAYER AG (DE) 1986-11-26 EP claimed
JP-61030586-A None JP disclosed
JP-1034982-A None JP disclosed
JP-61140573-A None JP disclosed
US-12433896-B2 Deuterated analogs of etifoxine, their derivatives and uses thereof GABA THERAPEUTICS INC. (US) 2025-10-07 US disclosed
JP-S61140573-A AMINOBENZOXAZINE DERIVATIVE AND PREPARATION THEREOF SUMITOMO CHEM CO LTD 1986-06-27 JP disclosed
EP-0176101-A1 Triazolopyridazines, and their production and use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-04-02 EP disclosed
JP-S6130586-A TETRAHYDROPHTHALIMIDE DERIVATIVE, ITS PREPARATION, AND HERBICIDE COMPRISING IT AS ACTIVE INGREDIENT SUMITOMO CHEM CO LTD 1986-02-12 JP disclosed
US-4537888-A Substituted benzoxazine derivatives and fungicidal use BAYER AKTIENGESELLSCHAFT (DE) 1985-08-27 US disclosed
JP-S06130586-A 0001-01-01 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12433896-B2 Deuterated analogs of etifoxine, their derivatives and uses thereof CYP2F1, CYP3A5, CYP4F3 KDM4E 1625/4885MEN1 985/4885ALDH1A1 1324/4885
US-20020194685-A1 Composition for dyeing keratin fibres, comprising a pyrazoline-4, 5-dione and an aromatic primary amine KRT18, KLK5, MARK1 KDM4E 376/4885MEN1 3401/4885ALDH1A1 185/4885
US-20020040508-A1 COMPOSITION FOR DYEING KERATIN FIBRES,COMPRISING A PYRAZOLIN-4,5-DIONE AND AN AROMATIC PRIMARY AMINE KRT18, KLK5, H1-5 KDM4E 292/4885MEN1 3896/4885ALDH1A1 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.